A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer
Abroad (travel likely)RecruitingPHASE1
Conditions
Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia
Contact: Study coordinator (Mark McGregor)Ballarat Base Hospital, Ballarat, Victoria, Australia
Contact: Study coordinator (James Ridgwell)Frankston Hospital, Frankston, Victoria, Australia
Contact: Study coordinator (Jacqui Thomson)